Home › Compare › BMNDF vs YUM

BMNDF vs YUM: Dividend Comparison 2026

BMNDF yields 18181.82% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMNDF wins by $658834.75M in total portfolio value
10 years
BMNDF
BMNDF
● Live price
18181.82%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$658834.86M
Annual income
$54,543,841,013.90
Full BMNDF calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — BMNDF vs YUM

📍 BMNDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMNDFYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMNDF + YUM cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BMNDF pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMNDF
Annual income on $10K today (after 15% tax)
$1,545,454.55/yr
After 10yr DRIP, annual income (after tax)
$46,362,264,861.82/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, BMNDF beats the other by $46,362,230,898.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMNDF + YUM for your $10,000?

BMNDF: 50%YUM: 50%
100% YUM50/50100% BMNDF
Portfolio after 10yr
$329417.48M
Annual income
$27,271,940,485.61/yr
Blended yield
8.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

BMNDF
No analyst data
Altman Z
-414.3
Piotroski
1/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMNDF buys
0
YUM buys
0
No recent congressional trades found for BMNDF or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMNDFYUM
Forward yield18181.82% ✓1.85%
Annual dividend / share$2.00$2.88 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%51.4% ✓
Portfolio after 10y$658834.86M ✓$107.0K
Annual income after 10y$54,543,841,013.90 ✓$39,957.33
Total dividends collected$553757.55M ✓$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: BMNDF vs YUM ($10,000, DRIP)

YearBMNDF PortfolioBMNDF Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$919,791$909,090.91$10,980$280.44+$908.8K → BMNDF
2$40,057,707$39,073,530.55$12,185$435.72+$40.05M → BMNDF
3$838,042,485$795,180,738.70$13,722$684.14+$838.03M → BMNDF
4$8,670,481,609$7,773,776,150.53$15,773$1,090.14+$8670.47M → BMNDF
5$46,860,761,379$37,583,346,056.88$18,650$1,773.02+$46860.74M → BMNDF
6$145,058,842,015$94,917,827,338.98$22,921$2,966.37+$145058.82M → BMNDF
7$292,512,437,337$137,299,476,380.97$29,685$5,158.69+$292512.41M → BMNDF
8$442,364,760,258$129,376,452,307.77$41,216$9,453.02+$442364.72M → BMNDF
9$564,757,963,223$91,427,669,747.44$62,672$18,571.31+$564757.90M → BMNDF
10$658,834,861,663$54,543,841,013.90$107,016$39,957.33+$658834.75M → BMNDF

BMNDF vs YUM: Complete Analysis 2026

BMNDF — Stock

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammation, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.

Full BMNDF Calculator →

YUM — Consumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this BMNDF vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMNDF vs SCHDBMNDF vs JEPIBMNDF vs OBMNDF vs KOBMNDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.